United States · Platforms & data · MarketWatch

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

Published by MarketWatch · United States 1 h ago

A deceleration in U.S. commercial contract growth gave some Wall Street analysts pause despite Palantir’s earnings beat.

Read the full article on MarketWatch Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)

Also worth reading

BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 52-Week Low - Here's What Happened

Clorox forecasts 3.5%-4.5% organic sales growth as input cost inflation rises to $240M

The Motley Fool

JAKKS Pacific: 3 Key Takeaways for Long-Term Investors

Disney eyes thousands of layoffs, asks managers to target 20% savings, Bloomberg News reports

Stock market after midterm elections: What S&P 500 history shows

Locksley Resources Options Expire Without Exercise